Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on gene therapy for intimal hyperplasia.

E D Reis1, M Skladany

  • 1Department of Surgery, Mount Sinai Medical Center, New York, NY 10029-6574, USA. ernane.reis@smtplink.mssm.edu

Bratislavske Lekarske Listy
|January 25, 2000
PubMed
Summary

Vessel wall trauma causes smooth muscle cell (SMC) activation, leading to intimal hyperplasia. Gene therapy shows promise for limiting SMC proliferation and treating vascular diseases like restenosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serial magnetic resonance imaging correlates with neurological outcome in an experimental model of spinal cord ischemia.

Spinal cord·2007
Same author

Lower-extremity wounds. 1: Vascular disease assessment.

Journal of wound care·2003
Same author

Lower-extremity wounds. 2. Management options.

Journal of wound care·2003
Same author

[Microvascular denudation of the femoral artery of the mouse as a model for restenosis].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2003
Same author

Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2003
Same author

Role of smooth muscle cell migration and proliferation in allograft vascular disease.

Transplantation proceedings·2002

Area of Science:

  • Vascular biology and regenerative medicine.
  • Molecular and cellular mechanisms of vascular injury.
  • Gene therapy applications in cardiovascular disease.

Background:

  • Vessel wall trauma triggers smooth muscle cell (SMC) activation and intimal hyperplasia.
  • This process is implicated in restenosis after angioplasty, bypass occlusion, and allograft rejection.
  • Current research explores genetic interventions to control SMC proliferation.

Purpose of the Study:

  • To review the role of SMC activation in vascular disease pathogenesis.
  • To explore the potential of gene therapy strategies for vascular repair.
  • To discuss the clinical translation challenges of gene therapy for arterial wall diseases.

Main Methods:

  • Review of existing literature on SMC biology and gene therapy.
  • Analysis of genetic intervention strategies targeting the cell cycle and post-injury events.
  • Discussion of delivery systems for local gene transfer to the arterial wall.

Main Results:

  • Genetic interventions have shown success in limiting SMC proliferation in vitro and in animal models.
  • Gene therapy approaches include antisense oligonucleotides, cytotoxic genes, and engineered cells.
  • Efficient local gene transfer to the arterial wall is crucial for clinical application.

Conclusions:

  • Smooth muscle cell proliferation is a key factor in vascular diseases following injury.
  • Gene therapy offers a promising therapeutic avenue for these conditions.
  • Advancements in delivery systems are essential for the successful clinical implementation of gene therapy in vascular medicine.

Related Experiment Videos